Final-stage preclinical development of a long-acting, non-opioid peptidomimetic drug for chronic pain
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210385
- Recipient
-
Alcamena Stem Cell Therapeutics, LLC UEI J6DAAQH7AQL8
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $5,599,963
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Halethorpe, MD 21227, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $710,830 | |
| Amendment | $0 | |
| Amendment | $2,678,483 | |
| Amendment | $1,119,967 | |
| Original award | $1,090,683 |
Quick answers
Who received award W81XWH2210385?
W81XWH2210385 was awarded to Alcamena Stem Cell Therapeutics, LLC by Defense Health Agency (Department of Defense) on May 15, 2022.
How much is award W81XWH2210385 worth?
$5,599,963 has been obligated on W81XWH2210385.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award